HMS Capital Management LLC cut its position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 74.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 738 shares of the semiconductor company's stock after selling 2,169 shares during the quarter. HMS Capital Management LLC's holdings in Synopsys were worth $316,000 at the end of the most recent quarter.
A number of other large investors have also recently made changes to their positions in the company. Cornerstone Planning Group LLC lifted its position in Synopsys by 275.0% during the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock worth $25,000 after acquiring an additional 44 shares during the period. Clal Insurance Enterprises Holdings Ltd lifted its position in Synopsys by 441.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock worth $28,000 after acquiring an additional 53 shares during the period. Ameriflex Group Inc. acquired a new stake in Synopsys during the 4th quarter worth approximately $29,000. Cloud Capital Management LLC acquired a new stake in Synopsys during the 1st quarter worth approximately $36,000. Finally, Meeder Asset Management Inc. lifted its position in Synopsys by 33.3% during the 1st quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock worth $45,000 after acquiring an additional 26 shares during the period. 85.47% of the stock is owned by institutional investors and hedge funds.
Synopsys Price Performance
NASDAQ SNPS traded up $8.35 during mid-day trading on Friday, hitting $606.52. The stock had a trading volume of 863,153 shares, compared to its average volume of 1,313,433. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a market cap of $94.11 billion, a price-to-earnings ratio of 43.79, a P/E/G ratio of 3.93 and a beta of 1.15. The company has a 50 day simple moving average of $570.29 and a 200 day simple moving average of $500.95. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01.
Synopsys (NASDAQ:SNPS - Get Free Report) last released its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, beating the consensus estimate of $3.40 by $0.27. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The firm had revenue of $1.60 billion during the quarter, compared to the consensus estimate of $1.60 billion. During the same period last year, the business posted $3.00 EPS. Synopsys's quarterly revenue was up 10.3% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. Equities analysts forecast that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the company. Needham & Company LLC reaffirmed a "buy" rating and set a $660.00 price objective (up from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. The Goldman Sachs Group assumed coverage on Synopsys in a research report on Thursday, July 10th. They set a "buy" rating and a $620.00 price objective for the company. Bank of America increased their price objective on Synopsys from $575.00 to $625.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Stifel Nicolaus set a $550.00 price target on Synopsys in a report on Monday, April 28th. Finally, KeyCorp raised their price target on Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a report on Thursday, July 10th. Twelve research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. According to MarketBeat.com, Synopsys presently has a consensus rating of "Moderate Buy" and a consensus price target of $626.79.
Check Out Our Latest Stock Analysis on Synopsys
Insider Activity at Synopsys
In related news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction that occurred on Monday, June 2nd. The stock was sold at an average price of $457.93, for a total value of $5,204,832.38. Following the completion of the transaction, the chief executive officer directly owned 71,589 shares of the company's stock, valued at $32,782,750.77. This trade represents a 13.70% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 7,310 shares of the firm's stock in a transaction on Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the transaction, the chief financial officer directly owned 15,291 shares of the company's stock, valued at $7,427,144.52. The trade was a 32.34% decrease in their position. The disclosure for this sale can be found here. Insiders sold 27,686 shares of company stock valued at $13,001,048 in the last ninety days. Corporate insiders own 0.62% of the company's stock.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Further Reading

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.